Menu
Back to User profile » Dr Chaogang Yang
Papers published by Dr Chaogang Yang:
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer [Corrigendum]
Zhang W, Yang C, Wang S, Xiang Z, Dou R, Lin Z, Zheng J, Xiong B
Cancer Management and Research 2022, 14:1845-1846
Published Date: 31 May 2022
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer
Zhang W, Yang C, Wang S, Xiang Z, Dou R, Lin Z, Zheng J, Xiong B
Cancer Management and Research 2021, 13:3601-3617
Published Date: 30 April 2021
M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22/PI3K/AKT signaling
Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, Xiong B
OncoTargets and Therapy 2019, 12:3051-3063
Published Date: 18 April 2019
Clinicopathological and prognostic significance of circulating tumor cells in patients with esophageal cancer: a meta-analysis
Hou J, Zou K, Yang C, Leng X, Xu Y
OncoTargets and Therapy 2018, 11:8053-8061
Published Date: 12 November 2018
Prognostic value of pre- and post-operative circulating tumor cells detection in colorectal cancer patients treated with curative resection: a prospective cohort study based on ISET device
Yang C, Shi D, Wang S, Wei C, Zhang C, Xiong B
Cancer Management and Research 2018, 10:4135-4144
Published Date: 4 October 2018
Prognostic value of circulating tumor cells detected with the CellSearch System in patients with gastric cancer: evidence from a meta-analysis
Yang C, Zou K, Yuan Z, Guo T, Xiong B
OncoTargets and Therapy 2018, 11:1013-1023
Published Date: 26 February 2018
Clinicopathological and prognostic significance of circulating tumor cells in patients with head and neck cancer: a meta-analysis
Sun T, Zou K, Yuan Z, Yang C, Lin X, Xiong B
OncoTargets and Therapy 2017, 10:3907-3916
Published Date: 4 August 2017